Showing results (181-190 of 486) with videos related to

Sort By:
Pageof 49
Frontiers in Oncology|October 4, 2021
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two CasesKristin Gerhardt, Madlen Jentzsch, Thomas Georgi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)Uwe Platzbecker, Martin Bornhäuser, Ulrich Germing, et al.
Transplantation|May 31, 2012
Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantationKonrad Mager, Rebekka Wehner, Felix Bahr, et al.
Haematologica|March 4, 2014
MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cellsLaleh S Arabanian, Fernando A Fierro, Friedrich Stölzel, et al.
Haematologica|August 10, 2012
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcomeBarbara Deschler, Gabriele Ihorst, Uwe Platzbecker, et al.
Frontiers in Oncology|February 24, 2025
Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasmsEsther Natalie Oliva, Shien Guo, Jennifer Lord-Bessen, et al.
The Lancet. Haematology|December 16, 2017
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trialMoshe Mittelman, Uwe Platzbecker, Boris Afanasyev, et al.
Acta Haematologica|October 28, 2024
Thiamine-Responsive Megaloblastic Anemia Syndrome Mimicking Myelodysplastic NeoplasmChristina Klötzer, Franziska Schnabel, Anne-Sophie Kubasch, et al.
Annals of Hematology|October 22, 2024
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trialFabio Efficace, Francesco Sparano, Massimo Breccia, et al.
British Journal of Haematology|February 26, 2013
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemiaBrigitte Mohr, Johannes Schetelig, Kerstin Schäfer-Eckart, et al.
Pageof 49